Back to Search
ILAN FEINGOLD, M.D.
M.D.
Pulmonary Disease Physician
NPI: 1477516623Individual
Specialties, Licenses & Credentials
Pulmonary Disease PhysicianPrimary
Internal Medicine — Pulmonary Disease
Code: 207RP1001X
ME39452(FL)
Research & Publications (10)
Discovery and SAR of cinnolines/quinolines as liver X receptor (LXR) agonists with binding selectivity for LXRbeta.
PMID 19394832·Bioorg Med Chem·2009
7-preclinical
LXR ligand lowers LDL cholesterol in primates, is lipid neutral in hamster, and reduces atherosclerosis in mouse.
PMID 19318684·J Lipid Res·2009
7-preclinical
Small molecule antagonists of the gonadotropin-releasing hormone (GnRH) receptor: structure-activity relationships of small heterocyclic groups appended to the 2-phenyl-4-piperazinyl-benzimidazole template.
PMID 19251413·Bioorg Med Chem Lett·2009
7-preclinical
Discovery of 6-({4-[2-(4-tert-butylphenyl)-1H-benzimidazol-4-yl]piperazin-1-yl}methyl)quinoxaline (WAY-207024): an orally active antagonist of the gonadotropin releasing hormone receptor (GnRH-R).
PMID 19271735·J Med Chem·2009
7-preclinical
Indazole-based liver X receptor (LXR) modulators with maintained atherosclerotic lesion reduction activity but diminished stimulation of hepatic triglyceride synthesis.
PMID 18973288·J Med Chem·2008
7-preclinical
Correlating efficacy in rodent cognition models with in vivo 5-hydroxytryptamine1a receptor occupancy by a novel antagonist, (R)-N-(2-methyl-(4-indolyl-1-piperazinyl)ethyl)-N-(2-pyridinyl)-cyclohexane carboxamide (WAY-101405).
PMID 18182558·J Pharmacol Exp Ther·2008
7-preclinical
2-phenyl-4-piperazinylbenzimidazoles: orally active inhibitors of the gonadotropin releasing hormone (GnRH) receptor.
PMID 18511284·Bioorg Med Chem·2008
7-preclinical
Discovery and implementation of transcriptional biomarkers of synthetic LXR agonists in peripheral blood cells.
PMID 18925943·J Transl Med·2008
3-trial
Further modification on phenyl acetic acid based quinolines as liver X receptor modulators.
PMID 17391964·Bioorg Med Chem·2007
7-preclinical
Discovery of phenyl acetic acid substituted quinolines as novel liver X receptor agonists for the treatment of atherosclerosis.
PMID 17034119·J Med Chem·2006
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 6200 SUNSET DR, SUITE 304
SOUTH MIAMI, FL 33143 - Phone
- (305) 662-1550
Quick Facts
- NPI
- 1477516623
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 10
Are you this provider?
Claim Your Profile